Different expression levels of α3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell lines

International Journal of Oncology

Volumn 29, Issue 3, 2006, Pages 557-566

  Escrevente, C ^a   Machado, E ^a   Brito, C ^a   Reis, C A ^b   Stoeck, A ^c   Runz, S ^c   Marme A ^d   Altevogt, P ^c   Costa, Júlia ^a  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Fucosyltransferase; Lewis determinant; Ovarian cancer

Indexed keywords

FUCOSE; FUCOSYLTRANSFERASE; GALACTOSIDE 3 FUCOSYLTRANSFERASE; GALACTOSIDE 3(4) LEVO FUCOSYLTRANSFERASE; GALACTOSIDE 3(4)-L-FUCOSYLTRANSFERASE; GALACTOSIDE 3-FUCOSYLTRANSFERASE; LECTIN;

ARTICLE; BLOOD GROUP LEWIS SYSTEM; CELL CULTURE; COLLOID CARCINOMA; CYSTADENOCARCINOMA; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; OVARY TUMOR; PAPILLARY CARCINOMA; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOCARCINOMA, MUCINOUS; BLOTTING, WESTERN; CARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; FEMALE; FUCOSE; FUCOSYLTRANSFERASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LECTINS; LEWIS BLOOD-GROUP SYSTEM; MICROSCOPY, FLUORESCENCE; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 33749360659     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.3.557     Document Type: Article

References (40)

1. Auersperg N, Wong AS, Choi KC, et al: Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22: 255-288, 2001.
2. Becker DJ and Lowe JB: Fucose: biosynthesis and biological function in mammals. Glycobiology 13: 41R-53R, 2003.
3. Dube DH and Bertozzi CR: Glycans in cancer and inflammation - potential for therapeutics and diagnostics. Nat Rev Drug Discov 4: 477-488, 2005.
4. Kukowska-Latallo JF, Larsen RD, Nair RP, et al: A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α(1,3/1,4)fucosyltransferase. Genes Dev 4: 1288-1303, 1990.
5. Lowe JB, Kukowska-Latallo JF, Nair RP, et al: Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis x and VIM-2 epitopes but not ELAM-1-dependent cell adhesion. J Biol Chem 266: 17467-17477, 1991.
6. Weston BW, Nair RP, Larsen RD, et al: Isolation of a novel human α(1,3) fucosyltransferase gene and molecular comparison to the human lewis blood group α(1,3/1,4) fucosyltransferase gene. Syntenic, homologous, nonallelic genes encoding enzymes with distinct acceptor substrate specificities. J Biol Chem 267: 4152-4160, 1992.
7. Weston BW, Smith PL, Kelly RJ, et al: Molecular cloning of a fourth member of a human α(1,3)fucosyltransferase gene family. Multiple homologous sequences that determine expression of the Lewis x epitopes. J Biol Chem 267: 24575-24584, 1992.
8. De Vries T, Srnka CA, Palcic MM, et al: Acceptor specificity of different length constructs of human recombinant alpha 1,3/4-fucosyltransferases. Replacement of the stem region and the transmembrane domain of fucosyltransferase V by protein A results in an enzyme with GDP-fucose hydrolyzing activity. J Biol Chem 270: 8712-8722, 1995.
9. Natsuka S, Gersten KM, Zenita K, et al: Molecular cloning of a cDNA encoding a novel human leukocyte alpha-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant. J Biol Chem 269: 16789-16794, 1994.
10. Kaneko M, Kudo T, Iwasaki H, et al: Alpha1,3-fucosyltransferase IX (Fuc-TIX) is very highly conserved between human and mouse; molecular cloning, characterization and tissue distribution of human Fuc-TIX. FEBS Lett 452: 237-242, 1999.
11. Roos C, Kolmer M, Mattila P, et al: Composition of Drosophila melanogaster proteome involved in fucosylated glycan metabolism. J Biol Chem 277: 3168-3175, 2002.
12. Baboval T and Smith FI: Comparison of human and mouse Fuc-TX and Fuc-TXI genes, and expression studies in the mouse. Mamm Genome 13: 538-541, 2002.
13. Ogawa J, Inoue H and Koide S: Expression of alpha-1,3-fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer. Cancer Res 56: 325-329, 1996.
14. Petretti T, Schulze B, Schlag PM, et al: Altered mRNA expression of glycosyltransferases in human gastric carcinomas. Biochim Biophys Acta 1428: 209-218, 1999.
15. Petretti T, Kemmner W, Schulze B, et al: Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut 46: 359-366, 2000.
16. Mas E, Pasqualini E, Caillol N, et al: Fucosyltransferase activities in human pancreatic tissue: comparative study between cancer tissues and established tumoral cell lines. Glycobiology 8: 605-613, 1998.
17. Numahata K, Satoh M, Handa K, et al: Sialosyl-Le(x) expression defines invasive and metastatic properties of bladder carcinoma. Cancer 94: 673-685, 2002.
18. Breton C, Oriol R and Imberty A: Conserved structural features in eukaryotic and prokaryotic fucosyltransferases. Glycobiology 8: 87-94, 1998.
19. Chandrasekaran EV, Jain RK and Matta KL: Ovarian cancer alpha 1,3-L-fucosyltransferase. Differentiation of distinct catalytic species with the unique substrate, 3′-sulfo-N-acetyllactosamine in conjunction with other synthetic acceptors. J Biol Chem 267: 23806-23814, 1992.
20. Costa J, Grabenhorst E, Nimtz M, et al: Stable expression of the Golgi form and secretory variants of human fucosyltransferase III from BHK-21 cells. J Biol Chem 272: 11613-11621, 1997.
21. Grabenhorst E, Nimtz M, Costa J, et al: In vivo specificity of human α1,3/4-fucosyltransferases III-VII in the biosynthesis of Lewis X and sialyl Lewis X motifs on complex-type N-glycans: coexpression studies from BHK-21 cells together with human β-trace protein. J Biol Chem 273: 30985-30994, 1998.
22. Kudo T, Ikehara Y, Togayachi A, et al: Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Lab Invest 78: 797-811, 1998.
23. Fukushi Y, Nudelman E, Levery SB, et al: Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). J Biol Chem 259: 10511-10517, 1984.
24. Fukushi Y, Hakomori S, Nudelman E, et al: Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. J Biol Chem 259: 4681-4685, 1984.
25. Abe K, McKibbin JM and Hakomori S: The monoclonal antibody directed to difucosylated type 2 chain (Fuc alpha 1 leads to 2Gal beta 1 leads to 4[Fuc alpha 1 leads to 3]GlcNAc; Y Determinant). J Biol Chem 258: 11793-11797, 1983.
26. Gast D, Riedle S, Riedle S, et al: L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int J Cancer 115: 658-665, 2005.
27. Morais VA, Serpa J, Palma AS, et al: Expression and characterization of recombinant human alpha-3/4- fucosyltransferase III from Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) cells using the baculovirus expression system. Biochem J 353: 719-725, 2001. (Pubitemid 32158341)
28. Faye L and Chrispeels MJ: Characterization of N-linked oligosaccharides by affinoblotting with concanavalin A-peroxidase and treatment of the blots with glycosidases. Anal Biochem 149: 218-224, 1985. (Pubitemid 16256972)
29. Singhal AK, Orntoft TF, Nudelman E, et al: Profiles of Lewisx-containing glycoproteins and glycolipids in sera of patients with adenocarcinoma. Cancer Res 50: 1375-1380, 1990. (Pubitemid 20090443)
30. Fukui S, Feizi T, Galustian C, et al: Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions. Nat Biotechnol 20: 1011-1017, 2002.
31. Montreuil J, Bouquelet S, Debray H, et al: Carbohydrate analysis - a practical approach. Rickwood D and Hames BD (eds). IRL Press, Oxford, 2003.
32. Fu D, Chen L and O'Neill RA: A detailed structural characterization of ribonuclease B oligosaccharides by 1H NMR spectroscopy and mass spectrometry. Carbohydr Res 261: 173-186, 1994. (Pubitemid 24257641)
33. Edge AS and Spiro RG: Presence of an O-glycosidically linked hexasaccharide in fetuin. J Biol Chem 262: 16135-16141, 1987.
34. Rice KG, Rao NB, and Lee YC: Large-scale preparation and characterization of N-linked glycopeptides from bovine fetuin. Anal Biochem 184: 249-258, 1990.
35. Spik G, Bayard B, Fournet B, et al: Studies on glycoconjugates. LXIV. Complete structure of two carbohydrate units of human serotransferrin. FEBS Lett 50: 296-299, 1975.
36. Cailleau-Thomas A, Coullin P, Candelier JJ, et al: FUT4 and FUT9 genes are expressed early in human embryogenesis. Glycobiology 10: 789-802, 2000. (Pubitemid 30642696)
37. Goelz SE, Hession C, Goff D, et al: ELFT: A gene that directs the expression of an ELAM-1 ligand. Cell Press 63: 1349-1356, 1990. (Pubitemid 120035083)
38. Federici MF, Kudryashov V, Saigo PE, et al: Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: serous and mucinous tumors exhibit distinctive patterns of expression. Int J Cancer 81: 193-198, 1999. (Pubitemid 29144746)
39. Cameron HS, Szczepaniak D and Weston BW: Expression of human chromosome 19p alpha(1,3)-fucosyltransferase genes in normal tissues. Alternative splicing, polyadenylation, and isoforms. J Biol Chem 270: 20112-20122, 1995.
40. Cailleau-Thomas A, Coullin P, Candelier JJ, et al: FUT4 and FUT9 genes are expressed early in human embryogenesis. Glycobiology 10: 789-802, 2000. (Pubitemid 30642696)